OR WAIT null SECS
January 31, 2014
PharmaCell enters an agreement purchase TiGenix therapy production facility.
With numerous biologics set to come off patent soon and the percentage of new therapeutics based on biomolecules growing, demand for contract manufacturing in the biopharma space is heating up.
January 02, 2014
NMR analysis provides crucial structural information of synthesized glycans while LC-MS/MS is ideal for quantitation of free sugars in biological matrices.
Antibody fragments pose unique challenges in terms of recovery, purification, and formulation.
With SMEs gaining wider recognition as the powerhouse of research and innovation in Europe, regulatory agencies are urging companies to engage with regulators early in the drug-development process.
December 19, 2013
CMC Biologics and OnoSynergy form an agreement from cell-line development.
December 12, 2013
BioWa and Lonza have entered into a licensing agreement with MedImmune for cell line technology.
December 04, 2013
Jill E. Sackman, D.V.M., PhD, senior consultant at Numerof & Associates, Inc. discusses the market forces impacting biopharmaceutical manufacturing
December 02, 2013
The European Union is strengthening its pioneering role in the regulation of biosimilars by further developing the basic rules for determining the levels of compatibility for this group of drugs. There are, however, some key issues that are not easy to resolve, as evident in a recent workshop on biosimilars organized by the European Medicines Agency (EMA).
November 15, 2013
Covance Inc. and Pathoquest have announced a collaboration to provide next-generation sequencing (NGS) based biosafety assessments to detect and identify viral contaminants within biologic compounds.